Arca

Pharma markets this week

Nov 16 to Nov 22, 2026

5 acquisitions, 11 funding rounds, 1 PDUFA date, 7 officer changes.

Acquisitions 5

Every acquisition since 2016

Funding rounds of $5 million or more, and IPOs 11

Funding rounds

VitriVax, Inc.

Series C of $87.0M

2026-11-18 · Led by F-Prime, RA Capital Management, Sanofi Ventures · Infectious disease · Biotech

Source

PDUFA dates companies have disclosed 1

PDUFA calendar

Capricor Therapeutics, Inc.

FDA goal date for Deramiocel (BLA), for upper limb impairment in patients 9 years old

2026-11-22 · Disclosed by Capricor Therapeutics, Inc.

Source

Officer and director changes 7

Verastem, Inc.

Change in directors or officers

2026-11-19 · Form 8-K, Item 5.02. The filing does not say who joined or left.

Source

NEXGEL, INC.

Change in directors or officers

2026-11-18 · Form 8-K, Item 5.02. The filing does not say who joined or left.

Source

Integer Holdings Corp

Change in directors or officers

2026-11-17 · Form 8-K, Item 5.02. The filing does not say who joined or left.

Source

Valion Bio, Inc.

Change in directors or officers

2026-11-16 · Form 8-K, Item 5.02. The filing does not say who joined or left.

Source